Serina Therapeutics (SER) Long-Term Debt Issuances (2023)
Serina Therapeutics' Long-Term Debt Issuances was $4.91 million in FY2025.
Analysis
Serina Therapeutics (SER) Long-Term Debt Issuances (2023) Analysis & Trends
- Long-Term Debt Issuances shows a five-year compound annual growth rate of 62.5% (FY2020 to FY2025).
- The FY2025 figure marks the lowest annual Long-Term Debt Issuances since FY2020.
- Per Business Quant data, Long-Term Debt Issuances in earlier years was $10.1 million in FY2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Issuance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,169.76 Bn | 1,138.35 Bn | 19.71 Bn | 8.94 Bn |
| 2 | Johnson & Johnson | 648.06 Bn | 567.92 Bn | 17.30 Bn | - |
| 3 | AbbVie | 503.37 Bn | 476.48 Bn | 12.70 Bn | - |
| 4 | Merck | 365.39 Bn | 319.77 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 303.45 Bn | 267.44 Bn | 11.24 Bn | 1.98 Bn |
| 6 | Astrazeneca | 269.03 Bn | 242.72 Bn | 12.86 Bn | - |
| 7 | Amgen | 242.08 Bn | 197.48 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.88 Bn | 169.07 Bn | 6.22 Bn | - |
| 9 | Pfizer | 172.39 Bn | 119.04 Bn | 10.94 Bn | - |
| 10 | Serina Therapeutics | 29.41 Mn | -11.33 Mn | - | - |
API Access
Serina Therapeutics Long-Term Debt Issuances API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=SER&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-debt-issuances", "ticker": "SER", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=SER&period=max&api_key=YOUR_API_KEY");
const data = await res.json();